Citations

Institution: Mayo Clinic Clear

Showing 10 of 108104 citations.

Predictors of outcome in 176 South African patients with peripartum cardiomyopathy
Blauwet, Lori A., Libhaber, Elena , Förster, Olaf, Tibazarwa, Kemi, Mebazaa, Alex, Sliwa, Karen , Hilfiker‐Kleiner, Denise , Sliwa, K

Heart | November 1, 2012 | Volume: 99 | Issue: 5 | Pages: 308-313

10.1136/heartjnl-2012-302760 | PMID 23118348 Get It

Objective Identify novel prognostic factors for patients with peripartum cardiomyopathy (PPCM). Design and setting Prospective cohort study conducted in a single tertiary care centre in South Africa. Patients 176 African women with newly diagnosed PPCM were studied. Interventions Clinical assessment, echocardiography and laboratory results were obtained at baseline and at 6 months. Main outcome measures Poor outcome was defined as the combined end point of death, left ventricular (LV) ejection fraction (LVEF) < 35%, or remaining in New York Heart Association (NYHA) functional class III/IV at 6 months. Complete LV recovery was defined as LVEF ≥55% at 6 months. Results Forty-five (26%) patients had a poor outcome. Multiple logistic regression analysis revealed that, after adjustment for age, NYHA functional class, LVEF and systolic blood pressure, increased left ventricular end systolic dimension (LVESD), lower body mass index (BMI) and lower total cholesterol at baseline were independent predictors of poor outcome (adjusted OR 1.09, 95% CI 1.04 to 1.15, p=0.001; OR 0.89, 95% CI 0.83 to 0.96, p=0.004, and OR 0.50, 95% CI 0.34 to 0.73, p=0.0004, respectively). Thirty (21%) of the 141 surviving patients with echocardiographic follow-up recovered LV function at 6 months. Multiple logistic regression analysis revealed that, after adjustment for NYHA functional class, LVEF and left ventricular end diastolic dimension, older age and smaller LVESD at baseline were predictors of LV recovery (OR 1.08, 95% CI 1.01 to 1.17, p=0.02 and OR 0.92, 95% CI 0.86 to 0.98, p=0.007, respectively). Conclusions This study suggests that increased LVESD, lower BMI and lower serum cholesterol at baseline may be independent predictors of poor outcome in patients with PPCM, while older age and smaller LVESD at baseline appear to be independently associated with a higher chance of LV recovery.
Interferon Regulatory Factor 5 in the Pathogenesis of Systemic Lupus Erythematosus
Cham, Candace M. , Ko, Kichul , Niewold, Timothy B.

Clinical and Developmental Immunology | November 1, 2012 | Volume: 2012 | Issue: No issue available | Pages: 1-11

10.1155/2012/780436 | PMID 23251221 Get It

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by multiple genetic risk factors, high levels of interferon alpha (IFN- α ), and the production of autoantibodies against components of the cell nucleus. Interferon regulatory factor 5 (IRF5) is a transcription factor which induces the transcription of IFN- α and other cytokines, and genetic variants of IRF5 have been strongly linked to SLE pathogenesis. IRF5 functions downstream of Toll-like receptors and other microbial pattern-recognition receptors, and immune complexes made up of SLE-associated autoantibodies seem to function as a chronic endogenous stimulus to this pathway. In this paper, we discuss the physiologic role of IRF5 in immune defense and the ways in which IRF5 variants may contribute to the pathogenesis of human SLE. Recent data regarding the role of IRF5 in both serologic autoimmunity and the overproduction of IFN- α in human SLE are summarized. These data support a model in which SLE-risk variants of IRF5 participate in a “feed-forward” mechanism, predisposing to SLE-associated autoantibody formation, and subsequently facilitating IFN- α production downstream of Toll-like receptors stimulated by immune complexes composed of these autoantibodies.
Minimising blood loss and transfusion in contemporary hip and knee arthroplasty
Watts, Chad D. , Pagnano, Mark W. , Pagnano, Mark W

The Journal of Bone and Joint Surgery. British volume | November 1, 2012 | Volume: 94-B | Issue: 11_Supple_A | Pages: 8-10

10.1302/0301-620x.94b11.30618 | PMID 23118371 Get It

Despite advances in contemporary hip and knee arthroplasty, blood loss continues to be an issue. Though blood transfusion has long been used to treat post-operative anemia, the associated risks are well established. The objective of this article is to present two practical and effective approaches to minimising blood loss and transfusion rates in hip and knee arthroplasty: the use of antifibrinolytic medications such as tranexamic acid and the adoption of more conservative transfusion indications.
Hip and knee arthroplasty 2011
Rosenberg, Aaron G., Berend, Michael E. , Berry, Daniel J. , Valle, Craig J. Della , MacDonald, Steven J. , Minas, T., Berry, Daniel J

The Journal of Bone and Joint Surgery. British volume | November 1, 2012 | Volume: 94-B | Issue: 11_Supple_A | Pages: 157-166

10.1302/0301-620x.94b11.30511 | PMID 23118407 Get It

This conversation represents an attempt by several arthroplasty surgeons to critique several abstracts presented over the last year as well as to use them as a jumping off point for trying to figure out where they fit in into our current understanding of multiple issues in modern hip and knee arthroplasty.
Diagnostic utility of direct immunofluorescence findings around hair follicles and sweat glands in immunobullous disease
Lehman, Julia S. , Camilleri, Michael , Lehman, Julia S

Journal of Cutaneous Pathology | November 1, 2012 | Volume: 40 | Issue: 2 | Pages: 230-235

10.1111/cup.12037 | PMID 23116305 Get It

Background Inherent to some immunobullous disorders is potential for intraepidermal or dermal–epidermal junction fragility, a phenomenon that may compromise biopsy specimen integrity and direct immunofluorescence (DIF) interpretation. In these situations, cutaneous adnexal structures (e.g. hair follicles, sweat apparatus) usually remain intact. Whether periadnexal DIF findings are reliable in diagnosing immunobullous conditions is unknown. Methods We evaluated 56 cutaneous specimens with diagnostic immunoglobulin (Ig) deposition patterns that contained adnexal structures. In a corollary study, we examined 145 hematoxylin‐eosin‐stained frozen specimens to determine biopsy factors associated with the presence of adnexal structures. Results Periadnexal DIF findings offered diagnostic sensitivity in conditions with linear or cell‐surface Ig deposition or lupus band. Periadnexal DIF findings were unreliable in dermatitis herpetiformis. Biopsy specimens from scalp and genitalia were most likely to contain folliculosebaceous units and sweat duct apparatus, respectively. Relative depth of biopsy correlated directly with the likelihood of identifying sweat duct apparatus but not folliculosebaceous units. Conclusions Periadnexal DIF findings may add diagnostic sensitivity in DIF evaluation of pemphigoid, pemphigus and lupus erythematosus. Pathologists can guide clinicians to biopsy certain anatomic sites and to obtain sufficient biopsy depth to increase the probability of capturing adnexal structures and, therefore, diagnostic yield from DIF specimens.
Imaging markers offer promise
Stevens, Suzanne, Kantarci, Kejal , Kantarci, Kejal

Neurology | November 1, 2012 | Volume: 79 | Issue: 24 | Pages: 2296-2297

10.1212/wnl.0b013e318278b6b7 | PMID 23115206 Get It

Migraine headache is present in the aura phase
Hansen, Jakob Møller , Silberstein, Stephen D., Saper, Joel R., Aurora, Sheena K. , Goadsby, Peter J. , Charles, Andrew , Lipton, Richard B. , Dodick, David W. , Goadsby, Peter J , Charles, Andrew

Neurology | November 1, 2012 | Volume: 79 | Issue: 20 | Pages: 2044-2049

10.1212/wnl.0b013e3182749eed | PMID 23115208 Get It

Cobalt and Chromium Measurement in Patients with Metal Hip Prostheses
Estey, Mathew P., Straeten, Catherine Van Der , Tower, Stephen S. , Hart, Alister , Moyer, Thomas P. , Diamandis, Eleftherios P.

Clinical Chemistry | November 1, 2012 | Volume: 59 | Issue: 6 | Pages: 880-886

10.1373/clinchem.2012.193037 | PMID 23115056 Get It

Design and Baseline Characteristics of Participants in a Phase III Randomized Trial of Celecoxib and Selenium for Colorectal Adenoma Prevention
Thompson, Patricia A. , Roe, Denise J. , Fales, Liane, Buckmeier, Julie A., Wang, Fang , Bhattacharyya, Achyut, Green, Sylvan, Hsu, Chiu‐Hsieh , Chow, H.‐H. Sherry , Ahnen, Dennis J. , Heigh, Russell I., Fay, David E., Jacobs, Elizabeth T. , Ashbeck, Erin L., Alberts, David S., Lance, Peter , Hamilton, Stanley R. , Boland, C. Richard , Martı́nez, Marı́a Elena

Cancer Prevention Research | October 31, 2012 | Volume: 5 | Issue: 12 | Pages: 1381-1393

10.1158/1940-6207.capr-12-0204 | PMID 23060037 Get It

Abstract COX inhibitors reduce colorectal adenoma recurrence by up to 45% and selenium supplementation may prevent colorectal cancer. Following colonoscopic adenoma resection, 1,600 men and women, ages 40 to 80 years, were randomized to celecoxib (400 mg daily), a selective COX-2 inhibitor, and/or selenium (200 μg daily as selenized yeast), or double placebo. The trial was initiated in November 2001. The primary trial endpoint is adenoma recurrence in each intervention group compared with placebo, as determined by surveillance colonoscopy conducted three to five years after baseline. Randomization was stratified by use of low-dose aspirin (81 mg) and clinic site. Following reports of cardiovascular toxicity associated with COX-2 inhibitors, the celecoxib arm was discontinued in December 2004 when 824 participants had been randomized. Accrual continued with randomization to selenium alone or placebo. Randomization of the originally planned cohort (n = 1,621) was completed in November 2008. A further 200 patients with one or more advanced adenomas (denoting increased risk for colorectal cancer) were accrued to enhance statistical power for determining intervention efficacy in this higher-risk subgroup. Accrual of the total cohort (n = 1,824) was completed in January 2011. Baseline cohort characteristics include: mean age 62.9 years; 65% male; body mass index (BMI) 29.1 ± 5.1; 47% taking low-dose aspirin while on trial; 20% with three or more adenomas; and 38% with advanced adenomas. Intervention effects on adenoma recurrence will be determined, and their modification by genetic background and baseline selenium level. The effect of selenium supplementation on risk for type II diabetes will also be reported. Cancer Prev Res; 5(12); 1381–93. ©2012 AACR.
Meningeal Layers Around Anterior Clinoid Process as a Delicate Area in Extradural Anterior Clinoidectomy : Anatomical and Clinical Study
Yoon, Byul Hee , Kim, Han Kyu, Park, Mun Sun, Kim, Seong Min , Chung, Seung Young , Lanzino, Giuseppe

Journal of Korean Neurosurgical Society | October 31, 2012 | Volume: 52 | Issue: 4 | Pages: 391

10.3340/jkns.2012.52.4.391 | PMID 23133730 Get It